All Equities articles
-
White papersFive Rules for Investing During the Coronavirus Outbreak
Pitfalls to avoid and opportunities to seek.
-
White papers
What is microfinance and why does it matter for investors?
Microfinance is a promising way to address global problems such as poverty, inequality and environmental damage. But what’s in it for investors?
-
White papers
How microfinance can help investors keep calm and carry on
Coronavirus has rocked traditional asset classes, but microfinance has historically been resilient in times of crisis. What’s next?
-
White papers
Blog | Why have Chinese equities outperformed?
FTSE Russell highlighted last week that China’s equity market had outperformed most developed and emerging equity markets since the beginning of the year. So, why did Chinese equities outperform global equity markets
-
White papers
Black swan or grey rhino: Should investors have seen COVID-19 coming?
The devastating coronavirus outbreak has prompted renewed discussion of “black swans”: rare, unexpected events that wreak havoc on markets and economies. But is COVID-19 really a black swan? And to what extent can investors ensure their portfolios are resilient to sudden shocks of this kind?
-
White papers
How have climate indexes fared during the Coronavirus sell-off?
As markets were rattled by the coronavirus pandemic and investors risk aversion spiked, how did climate-focused strategies fare?
-
White papers
COVID-19: This time is different?
While the COVID-19 pandemic may be unlike anything financial markets have experienced before, the past still offers valuable lessons for investors trying to make sense of the crisis, explains Euan Munro.
-
White papers
A test of character for Europe
The contagion of the corona virus continues, but at a slower pace. In the first days of April the total number of recorded cases, now well over one million globally, was rising by about 8.5% a day, vs. 12% around 25 March.
-
White papers
Macroeconomic Picture - April 2020
Heading towards a sharp contraction in H1; H2 recovery shaped by the duration of the crisis and by the effectiveness of the unprecedented policy response, once the post-containment normalization phase starts.While a state of emergency has been declared by the President, almost all states are implementing emergency measures with various degrees of severity, from preventing gatherings to statewide quarantines.
-
White papers
Oil Jumps, Jobs Slump, More Fiscal Help Coming
President Trump expects Saudi Arabia and Russia to cut oil production and prices surged ~25% on the news. Initial claims for unemployment insurance benefits skyrocketed, doubling the previous week’s record and there is more talk of future fiscal packages.
-
White papers
Blog | Valuations have fallen sharply, but buyers beware
On all metrics, equity valuations are at multiyear lows. But until there’s more clarity on the pandemic’s impact on earnings, stock pricing is more noise than signal. With global equity benchmarks in bear-market territory, valuations haven’t been this low in years. But given the still-opaque outlook for world economies and earnings, the caveat of “let the buyer beware” remains an apt warning.
-
White papers
Coronavirus: the long-term impacts on emerging markets
Beyond the shockwaves, immense uncertainty and eventual recovery, each economic crisis changes the way society and corporations operate, leaving scars but also spurring innovation.
-
White papers
Viral volatility: how Covid-19 is infecting sentiment
The stock markets are characterised by long stretches of calm punctuated by times of crisis – the most recent of which is the ongoing coronavirus pandemic. Amid the rapid global spread of Covid-19, worries about economic growth have intensified and equity markets have suffered steep pullbacks.
-
White papers
Pandemic panic: making sense of investor behaviour
The current market shakeout has caused extreme reactions among both consumers and investors. But are we wrong to suggest that investors are behaving irrationally in response to this coronavirus crisis? In this piece, we look at the market moves over the past month and consider how investors can use an active approach to confront their internal biases.
-
White papers
Blog | Why has the FTSE 250 underperformed the FTSE 100 in Q1?
What a difference a few months can make. Only last autumn, the FTSE 250 Index was standing out for significantly outperforming its larger counterpart, the FTSE 100 Index. However, this meant that the small-cap index only had further to fall since the coronavirus sell-off started in February.
-
White papers
Are investors too complacent about the coronavirus?
In the latest of our editorial series, Link, AIQ brings members of Aviva Investors’ investment strategy, equity and debt teams together to discuss the prospects for financial markets and the world economy in the face of the coronavirus epidemic.
-
White papers
Blog | China outperforms in worst quarter for global stocks
Call it a case of first in, first out: Despite the distinction of being the initial epicenter of the now global coronavirus outbreak, China’s equity market suffered far less than both the emerging and developed indexes in the March downdraft and for the year so far.
-
White papers
Blog | Russell 1000 leads Russell 2000 in stampede to safety
The outperformance of US large caps over their small-cap peers that began last June persisted through the March 2020 turmoil, underpinned by the extreme investor run for safer ground. The Russell 1000 fell 20.2% in Q1 2020, versus a drop of 30.6% for the Russell 2000. While both indexes enjoyed sharp rebounds in late March, only the Russell 1000 is back in positive territory for the longer term (up 4.9% since January last year). The Russell 2000 remains deeply in the red (down 12.9% for the same period).
-
White papers
How Could Covid-19 Affect 5G?
The way we live, work and learn has shifted markedly since the Covid-19 outbreak. With greater reliance on online resources, we see an increased demand for faster network speeds that could be enabled by 5G. How could the pandemic affect 5G rollouts? Where are the opportunities? Watch YT Boon, Director of Research – Asia, as he shares his insights on the demand for this service.
-
White papers
Audio Insight: The Course of COVID-19
Terri Towers, Senior Healthcare Research Analyst looks at the current progression of the COVID-19 pandemic as well as her views on inflection points and treatment timelines.
